New safer insulin prescribing summary
NICE has published new advice about prescribing insulin to support improved clinical practice.
The online resource called ‘Safer insulin prescribing’ summarises the evidence base in the therapeutic area to support medicines optimisation, but is not formal NICE guidance.
The document has been released this month. It includes the following options for local implementation:
- Clinicians should ensure that people with diabetes who are receiving insulin therapy are given information about awareness and management of hypoglycaemia.
- People with diabetes who use insulin and who drive should be aware of the need to notify the Driver and Vehicle Licensing Agency (DVLA). Clinicians should refer to chapter 3 of the DVLA’s Assessing fitness to drive – a guide for healthcare professionals for more information.
- Clinicians should be aware of ‘sick-day’ rules and should ensure that people with diabetes who are receiving insulin therapy are given appropriate information about these.
- Several new insulin products have been launched recently, including high-strength, fixed combination and biosimilar insulins. Clinicians should be aware of the differences between these products and ensure that people receive appropriate training on their correct use. People should be advised to only use insulin in the way they have been trained because using it any other way may result in a dangerous overdose or underdose.
- Adults who are using insulin therapy should receive a patient information booklet and an Insulin Passport.
To access the resource, click here.